Therapeutic drug monitoring as a tool in treating HIV infection

被引：28

作者：

Khoo, SH ^{[1
]}

Gibbons, SE ^{[1
]}

Back, DJ ^{[1
]}

机构：

[1] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool HIV Pharmacol Grp, Liverpool L69 3GE, Merseyside, England

来源：

AIDS | 2001年 / 15卷

关键词：

therapeutic drug monitoring; HIV; protease inhibitors; non-nucleoside reverse transcriptase inhibitors;

D O I：

10.1097/00002030-200100005-00021

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：S171 / S181

页数：11

共 61 条

[1]

Aarnouste R, 2001, 8 C RETR OPP INF CHI

[2] Indinavir concentrations and antiviral effect [J].

Acosta, EP ;

Henry, K ;

Baken, L ;

Page, LM ;

Fletcher, CV .

PHARMACOTHERAPY, 1999, 19 (06) :708-712

[3] Pharmacodynamics of human immunodeficiency virus type 1 protease inhibitors [J].

Acosta, EP ;

Kakuda, TN ;

Brundage, RC ;

Anderson, PL ;

Fletcher, CV .

CLINICAL INFECTIOUS DISEASES, 2000, 30 :S151-S159

[4] The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites [J].

Barry, MG ;

Khoo, SH ;

Veal, GJ ;

Hoggard, PG ;

Gibbons, SE ;

Wilkins, EGL ;

Williams, O ;

Breckenridge, AM ;

Back, DJ .

AIDS, 1996, 10 (12) :1361-1367

[5]

Burger DM, 1998, ANTIVIR THER, V3, P215

[6]

Burger DM, 1998, AIDS, V12, pS61

[7]

BURGER DM, 2000, 1 INT WORKSH CLIN PH

[8]

BURGER DM, 2001, 2 INT WORKSH CLIN PH

[9]

CHODAKEWITZ J, 1998, 1I INT C AIDS GEN JU

[10]

Churchill DR, 1998, AIDS, V12, pS9

← 1 2 3 4 5 6 7 →